Navigation Links
Adeptia Named a Value Leader in EMA Radar for Integration Technologies for Hybrid Cloud: Q4 2012
Date:2/21/2013

throughout. […] EBIM takes the state-of-the-art meta-driven approach to creation and deployment of process flows. The process flow that is deployed is an XML file and at run-time the execution occurs based on activity rules that are read by the process engine from the services repository.”

  • Functionality: “The fact that [Adeptia] was designed for use by business users is evident in the product and was mentioned as a differentiator in customer interviews. This ease of use is enabled by an intuitive and essentially “point and click” GUI. Adeptia has also incorporated high levels of manageability into its product, with reporting on time spent at each tier, error log entries, and hung transactions, for example.”
  • Deployment and Administration: Adeptia scored well in this area, based on fast deployment, a variety of on-premise and public Cloud-based form factors, and broad database options. They also offer a wide range of support options, and customers indicate that the customer support experience is exceptional. One of the few integration solutions that can realistically be administered by a non-expert.
  • Differentiators include: state-based processing supporting long running transactions, clustering and fault tolerance, process recovery and rollback.
  • “Adeptia’s unique platform can help companies stand-out in the marketplace, and deliver value to both internal and external clients,” said Deepak Singh, Adeptia President and CTO. “We have simplified the integration process, delivering a seamless, cost-effective experience for both IT and business stakeholders. Also eliminating, in many cases, the need for hiring outside professional services vendors.”

    About the EMA Radar Report:

    The EMA Radar Report (produced by Enterprise Management Associates, a leading industry analyst firm) delivers an in-depth analysis of industry-leading vendors and vendor products, including their overall market
    '/>"/>

    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Adeptia Announces 75% Revenue Increase for 2012 Calendar Year
    2. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
    3. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
    4. Sequenom Named to NASDAQ Global Select Market
    5. U of Toronto experiment named top breakthrough of 2011 by Physics World
    6. BioStorage Technologies Mike Reffeitt Named "CFO of the Year" by Indianapolis Business Journal
    7. Superior Controls of Seabrook, NH Named System Integrator of the Year for 2012 by Control Engineering Magazine
    8. Royals Batter Billy Butler Named Hutch Award Winner
    9. Life Technologies Plant in Austin, Texas Named One of IndustryWeeks Top Ten Best Plants for 2011
    10. Kimberly-Clarks Bob Stargel Named One of Savoy Magazines Top 100 Most Influential Blacks in Corporate America
    11. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... ... 2015 , ... A study by a multidisciplinary research team, ... adapt through genetic modifications to fight back against the effects of medication designed ... insights may provide clues to new ways to treat notoriously difficult-to-cure fungal infections ...
    (Date:7/6/2015)... Wellesley, Mass. (PRWEB) , ... July 06, 2015 ... ... development of simpler and cheaper molecular diagnostic tests are key drivers of the ... projected growth of personalized medicine and the introduction of new companion diagnostic tests ...
    (Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
    (Date:7/3/2015)... , ... July 03, 2015 , ... ... by Fortune 500 companies and professional service industries alike-- typically known for its ... clients laugh, honor a good cause and break from their day jobs. , ...
    Breaking Biology Technology:Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 2Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 3Worcester Polytechnic Institute Co-directs Study That Provides New Insights into the Genetics of Drug-Resistant Fungal Infections 4Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2The Alexander Group Declares Their Independence with a Bit of Levity 2
    ... 2011 Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced that ... the filing of the Marketing Authorization Application (MAA) for ... the treatment and prevention of bleeding in individuals with ... that it will begin its regulatory review process of ...
    ... Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO ) announced ... Jim Holmes, Lifeline,s CEO said "While our efforts ... have not been successful.  We now are considering alternatives should ... Lifeline is not reflected in the current lack of liquidity ...
    ... have developed polymers that fluoresce in the presence of bacteria, ... wound infection using ultra-violet light. When contained ... of fluorescence detected will alert clinicians to the severity of ... which bind to either gram negative or gram positive bacteria ...
    Cached Biology Technology:Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B 2Inspiration Biopharmaceuticals Announces Acceptance of European Marketing Authorization Application for IB1001 for the Treatment of Hemophilia B 3Lifeline Biotechnologies and Depository Trust Company 2Sheffield scientists shine a light on the detection of bacterial infection 2
    (Date:6/26/2015)... June 26, 2015 ATL Technology, LLC, a top ... specialties in single use solutions, headquartered in Springville, ... (a California corporation with locations in ... San Jose, Costa Rica ). This acquisition ... with ATL Technology,s existing facility in ...
    (Date:6/25/2015)... PRINCETON, N.J. , June 25, 2015  TAKE ... awarded a patent by the United States Patent and ... Data Standardization". This process leverages TAKE Solutions, Clinical Accelerators ... by over 50% (when compared to standardization without the ... At the heart ...
    (Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
    Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
    ... new study shows that high school athletes playing at higher ... phenomenon attributed to physiological changes in the brain causing it ... the first time any research has linked altitude to sports-related ... the Colorado School of Public Health and co-author of the ...
    ... Study of the Liver (EASL) today publishes their revised ... C virus infection (HCV) (1). The EASL guidelines, ... designed to help physicians and other healthcare providers optimise ... It is estimated that approximately 160 million individuals, ...
    ... the development of tumours in over one per cent of ... gene CUX1 has been broadly linked to cancer development. ... pathway is activated that increases tumour growth. Drugs that inhibit ... and are in development thus highlighting a potential new targeted ...
    Cached Biology News:Study shows first link between altitude and concussion 2EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus 2EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus 3Gene promotes 1 in 100 of tumors 2
    Human Aminopeptidase P2/XPNPEP2 Affinity Purified PAb ENTREZ GeneID: 7512...
    Collected from 8-12 week old sexually mature rats. Pricing: $100/unit for 1 - 10 units...
    PlusOne Acrylamide PAGE, 1 kg. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
    ... RNA Quantitation Kit is one of ... the quantitation of RNA in solution. ... more sensitive than absorbance measurements. As ... detected with fluorescence microplate readers and ...
    Biology Products: